Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F19%3A00520917" target="_blank" >RIV/61388971:_____/19:00520917 - isvavai.cz</a>

Result on the web

<a href="https://doi.org/10.3390/molecules24071251" target="_blank" >https://doi.org/10.3390/molecules24071251</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3390/molecules24071251" target="_blank" >10.3390/molecules24071251</a>

Result language

angličtina

Original language name

Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials

Original language description

Glucans are part of a group of biologically active natural molecules and are steadily gaining strong attention not only as an important food supplement, but also as an immunostimulant and potential drug. This paper represents an up-to-date review of glucans (β-1,3-glucans) and their role in various immune reactions and the treatment of cancer. With more than 80 clinical trials evaluating their biological effects, the question is not if glucans will move from food supplement to widely accepted drug, but how soon.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

10606 - Microbiology

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2019

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Molecules

ISSN

1420-3049

e-ISSN

—

Volume of the periodical

24

Issue of the periodical within the volume

7

Country of publishing house

CH - SWITZERLAND

Number of pages

17

Pages from-to

1251

UT code for WoS article

000464959200006

EID of the result in the Scopus database

2-s2.0-85063750846